menu
    • menu

    Company profile for Abzena Ltd

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abzena is a life sciences group with its headquarters in the UK and two sites in the US. Abzena offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals, products based on antibodies or other proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abzena Ltdunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Babraham Research Campus Cambridge CB22 3AT
    Telephone
    Telephone
    +44 1223 903498
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abzena.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abzena Tops Frost & Sullivan's ADC CDMO Radar Report
    Abzena Tops Frost & Sullivan's ADC CDMO Radar Report

    17 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abzena-recognized-as-a-market-leading-antibody-drug-conjugate-cdmo-in-frost--sullivan-radar-report-302715867.html

    PR NEWSWIRE
    17 Mar 2026
    Share Share
    Abzena & Mabqi Enter Strategic Development Services Partnership
    Abzena & Mabqi Enter Strategic Development Services Partnership

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/abzena-and-mabqi-announce-strategic-partnership-to-offer-integrated-discovery-through-development-solution

    PHARMIWEB
    06 Nov 2025
    Share Share
    Orion, Abzena Secure Exclusive Commercial License For Antibody
    Orion, Abzena Secure Exclusive Commercial License For Antibody

    24 Oct 2025

    // PRESS RELEASE

    https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2025/orion-and-abzena-announce-exclusive-commercial-license-for-abzenas-antibody/

    PRESS RELEASE
    24 Oct 2025
    Share Share
    Abzena Enhances AbZelectPRO™ with New GS Knockout Platforms
    Abzena Enhances AbZelectPRO™ with New GS Knockout Platforms

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abzena-enhances-abzelectpro-cell-line-offering-with-new-gs-knockout-platforms-302556214.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    Abzena Appoints Geoffrey M. Glass as Chief Executive Officer
    Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

    22 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abzena-appoints-geoffrey-m-glass-as-chief-executive-officer-302510732.html

    PR NEWSWIRE
    22 Jul 2025
    Share Share
    Abzena Establishes Scientific Advisory Board for Innovation
    Abzena Establishes Scientific Advisory Board for Innovation

    15 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abzena-announces-establishment-of-scientific-advisory-board-to-support-innovation-strategy-302456771.html

    PR NEWSWIRE
    15 May 2025
    Share Share

    ABOUT THIS PAGE

    Contact Abzena Ltd and get a quotation

    Abzena Ltd is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of THIOBRIDGE VC-PAB-MMAE bulk with DMF offered by Abzena Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search